Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
IRLAB Therapeutics
IRLAB’s CEO Intends to Step Down During the First Quarter of 2027
September 3, 2026
New Number of Shares and Votes in IRLAB Therapeutics AB
August 31, 2026
IRLAB Publishes Interim Report for The Period January – June 2026
August 26, 2026
IRLAB: Invitation to The Interim Report for Q2 2026 Presentation and Webcast
August 20, 2026
IRLAB’s Drug Candidate IRL757 Receives the Generic Name Linepemat from The WHO
August 19, 2026
New Number of Shares and Votes in IRLAB Therapeutics AB
July 31, 2026
IRLAB Publishes Interim Report for The Period January – March 2026
May 6, 2026
IRLAB: Invitation to the Interim Report for Q1 2026 Presentation and Webcast
May 5, 2026
IRLAB publishes the Annual Report for 2025
May 5, 2026
Nomination Committee’s proposal to the Board of Directors for IRLAB Therapeutics’ Annual General Meeting 2026
May 3, 2026
1
2
Next Page
→